drugset / Trial / NCT01093508
Single-dose Safety Study of APD916 in Healthy Volunteers
RandomizedQuadruple-blindTreatment
Summary
The APD916-001 study is designed primarily to evaluate the safety and tolerability of APD916 when administered as a single dose
Timeline
- Start
- 2010-03
- Primary completion
- 2010-04
- Completion
- 2010-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | APD916 | Unknown | 1 mg | — |
| Subject | APD916 | Unknown | 2 mg | — |
| Subject | APD916 | Unknown | 5 mg | — |
| Subject | APD916 | Unknown | 10 mg | — |
| Subject | APD916 | Unknown | 20 mg | — |
| Subject | APD916 | Unknown | 30 mg | — |
| Subject | APD916 | Unknown | 45 mg | — |
| Subject | APD916 | Unknown | 70 mg | — |
| Subject | APD916 | Unknown | 90 mg | — |